Hydantoin and succinimide-substituted derivatives of spiroindanylcamphorsulfonyl oxytocin antagonists
CA 2078262 A1 · Owner: Evans, Ben E. · Inventors: Hobbs, Doug W.; Gilbert, Kevin; Veber, Daniel F.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Compounds of the formula: where R is Het-R', where Het is substituted 5 membered heterocyclic rings containing 1 or 2 99/FPG57, -ii- 18538, heteroatoms, wherein said heteroatoms are N; R' is independently one or more of hydrogen oxo amino or, unsubstituted or substituted alkyl where said alkyl, substituent is independently one or more of hydroxyl amino, oxo, sulfonyl, alkylsulfonyl, carboxyl phenyl, indole, alkoxycarbonyl, alkoxycarbonylamino imidazole or pyrrolidine. These compounds are oxytocin and vasopressin antagonists useful in the treatment of preterm labor, dysmenorrhea and for the, stoppage of labor preparatory to cesarean delivery timing of parturition, uterine hyperactivity …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 15, 1992. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 15, 2012.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 15, 2014.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.